These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18025264)

  • 1. Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor alpha tyrosine-phosphorylated peptide.
    Varricchio L; Migliaccio A; Castoria G; Yamaguchi H; de Falco A; Di Domenico M; Giovannelli P; Farrar W; Appella E; Auricchio F
    Mol Cancer Res; 2007 Nov; 5(11):1213-21. PubMed ID: 18025264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
    Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F
    Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between EGFR and extranuclear steroid receptors.
    Migliaccio A; Castoria G; Di Domenico M; Ciociola A; Lombardi M; De Falco A; Nanayakkara M; Bottero D; De Stasio R; Varricchio L; Auricchio F
    Ann N Y Acad Sci; 2006 Nov; 1089():194-200. PubMed ID: 17261767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-steroid hormones and EGF signalling in breast and prostate cancer cells: targeting the association of Src with steroid receptors.
    Auricchio F; Migliaccio A; Castoria G
    Steroids; 2008 Oct; 73(9-10):880-4. PubMed ID: 18342899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth.
    Migliaccio A; Varricchio L; De Falco A; Castoria G; Arra C; Yamaguchi H; Ciociola A; Lombardi M; Di Stasio R; Barbieri A; Baldi A; Barone MV; Appella E; Auricchio F
    Oncogene; 2007 Oct; 26(46):6619-29. PubMed ID: 17486077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells.
    Castoria G; Giovannelli P; Lombardi M; De Rosa C; Giraldi T; de Falco A; Barone MV; Abbondanza C; Migliaccio A; Auricchio F
    Oncogene; 2012 Nov; 31(46):4868-77. PubMed ID: 22266855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
    Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
    Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Src and ER blockade impairs human breast cancer proliferation in vitro and in vivo.
    Chen Y; Alvarez EA; Azzam D; Wander SA; Guggisberg N; Jordà M; Ju Z; Hennessy BT; Slingerland JM
    Breast Cancer Res Treat; 2011 Jul; 128(1):69-78. PubMed ID: 20669046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking γ-aminobutyric acid A receptor to epidermal growth factor receptor pathways activation in human prostate cancer.
    Wu W; Yang Q; Fung KM; Humphreys MR; Brame LS; Cao A; Fang YT; Shih PT; Kropp BP; Lin HK
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):69-79. PubMed ID: 24296312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells.
    Pandini G; Genua M; Frasca F; Squatrito S; Vigneri R; Belfiore A
    Cancer Res; 2007 Sep; 67(18):8932-41. PubMed ID: 17875736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexachlorobenzene induces cell proliferation and IGF-I signaling pathway in an estrogen receptor alpha-dependent manner in MCF-7 breast cancer cell line.
    García MA; Peña D; Alvarez L; Cocca C; Pontillo C; Bergoc R; de Pisarev DK; Randi A
    Toxicol Lett; 2010 Feb; 192(2):195-205. PubMed ID: 19879930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unliganded estrogen receptor alpha inhibits breast cancer cell growth through interaction with a cyclin-dependent kinase inhibitor (p21(WAF1)).
    Maynadier M; Ramirez JM; Cathiard AM; Platet N; Gras D; Gleizes M; Sheikh MS; Nirde P; Garcia M
    FASEB J; 2008 Mar; 22(3):671-81. PubMed ID: 17911387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer.
    Chu I; Arnaout A; Loiseau S; Sun J; Seth A; McMahon C; Chun K; Hennessy B; Mills GB; Nawaz Z; Slingerland JM
    J Clin Invest; 2007 Aug; 117(8):2205-15. PubMed ID: 17627304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
    Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS
    Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between steroid receptors and neoplastic progression in sarcoma tumors.
    Fiorelli A; Ricciardi C; Pannone G; Santoro A; Bufo P; Santini M; Serpico R; Rullo R; Pierantoni GM; Di Domenico M
    J Cell Physiol; 2011 Nov; 226(11):2997-3003. PubMed ID: 21302296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid signalling pathway activation by androgens in epithelial and stromal cells.
    Castoria G; Lombardi M; Barone MV; Bilancio A; Di Domenico M; De Falco A; Varricchio L; Bottero D; Nanayakkara M; Migliaccio A; Auricchio F
    Steroids; 2004 Aug; 69(8-9):517-22. PubMed ID: 15288763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of ER-α36, Src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cells.
    Zhang XT; Ding L; Kang LG; Wang ZY
    Oncol Rep; 2012 Jun; 27(6):2057-65. PubMed ID: 22426783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.